Europe Bioelectric Medicine Market 2020-2030 by Product Type (Implantable, Non-invasive), End User, and Country: Trend Forecast and Growth Opportunity

About the Report

About the Report

Bioelectric medicines, also known as electroceuticals, are medical devices that are used to restore health in patients. Bioelectric medicines function through neurostimulation and modulation of the nervous systems through electrical impulses. Europe bioelectric medicine market was valued at USD 5,859.6 million in 2020 and will grow by 6.4% annually over 2020-2030 owing to the growing geriatric population and rising acceptance of bioelectric medicines.

Highlighted with 70 tables and 43 figures, this 141-page report Europe Bioelectric Medicine Market 2020-2030 by Product Type (Implantable, Non-invasive), End User, and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire Europe bioelectric medicine market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate/forecast from 2020 till 2030 with 2019 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure

Growth Drivers

Restraints and Challenges

Emerging Product Trends & Market Opportunities

Porter's Fiver Forces

The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe bioelectric medicine market in every aspect of the classification from perspectives of Product Type, End User, and Country.

Based on Product Type, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Implantable Bioelectric Medicine

o Cardiac Pacemaker

o Implantable Cardioverter Defibrillators (ICD)

o Spinal Cord Stimulators (split into Chronic Pain, Failed Back Syndrome (FBSS), Ischemia by application)

o Cochlear Implants

o Deep Brain Stimulators (split into Parkinson's Disease, Tremor, Depression, Other Deep Brain Stimulation Applications by application)

o Vagus Nerve Stimulators

o Sacral Nerve Stimulators (split into Urinary Incontinence and Fecal Incontinence by application)

o Retinal Implants

o Other Implantable Bioelectric Medicines

Non-invasive Bioelectric Medicine

o Transcutaneous Electrical Nerve Stimulators

o Transcranial Magnetic Stimulation (TMS)

o Pulsed Electromagnetic Field Therapy

o Other Non-invasive Bioelectric Medicines

Based on End User, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Hospitals and Clinics

Research Institutes

Individual Users

Geographically, the following national/local markets are fully investigated:

Germany

UK

France

Spain

Italy

Russia

Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

For each key country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of the regional market by country and split of key national markets by Product Type and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in Europe bioelectric medicine market are assayed quantitatively and qualitatively through GMD's Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):

Abbott Laboratories

BIOTRONIK SE & Co. KG

Boston Scientific Corporation

Cochlear Limited

electroCore, Inc.

Inspire Medical Systems, Inc.

LivaNova PLC

Medtronic PLC

NeuroMetrix, Inc

Nevro Corp.

Nuvectra Corporation

OMRON CORPORATION

Pixium Vision

Second Sight Medical Products Inc

SetPoint Medical

Sonova Holding AG

St. Jude Medical, Inc.

Stimwave LLC

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Products


Companies

Key Players (this may not be a complete list and extra companies can be added upon request):

Abbott Laboratories

BIOTRONIK SE & Co. KG

Boston Scientific Corporation

Cochlear Limited

electroCore, Inc.

Inspire Medical Systems, Inc.

LivaNova PLC

Medtronic PLC

NeuroMetrix, Inc

Nevro Corp.

Nuvectra Corporation

OMRON CORPORATION

Pixium Vision

Second Sight Medical Products Inc

SetPoint Medical

Sonova Holding AG

St. Jude Medical, Inc.

Stimwave LLC

Table of Contents

Table of Contents

1 Introduction 7

1.1 Industry Definition and Research Scope 7

1.1.1 Industry Definition 7

1.1.2 Research Scope 8

1.2 Research Methodology 11

1.2.1 Overview of Market Research Methodology 11

1.2.2 Market Assumption 12

1.2.3 Secondary Data 12

1.2.4 Primary Data 12

1.2.5 Data Filtration and Model Design 13

1.2.6 Market Size/Share Estimation 14

1.2.7 Research Limitations 15

1.3 Executive Summary 16

2 Market Overview and Dynamics 18

2.1 Market Size and Forecast 18

2.1.1 Impact of COVID-19 on World Economy 19

2.1.2 Impact of COVID-19 on the Market 21

2.2 Major Growth Drivers 23

2.3 Market Restraints and Challenges 29

2.4 Emerging Opportunities and Market Trends 32

2.5 Porter's Fiver Forces Analysis 36

3 Segmentation of Europe Market by Product Type 40

3.1 Market Overview by Product Type 40

3.2 Implantable Bioelectric Medicine 42

3.2.1 Cardiac Pacemaker 44

3.2.2 Implantable Cardioverter Defibrillators (ICD) 45

3.2.3 Spinal Cord Stimulators 46

3.2.4 Cochlear Implants 47

3.2.5 Deep Brain Stimulators 48

3.2.6 Vagus Nerve Stimulators 49

3.2.7 Sacral Nerve Stimulators 50

3.2.8 Retinal Implants 51

3.2.9 Other Implantable Bioelectric Medicines 52

3.3 Non-invasive Bioelectric Medicine 53

3.3.1 Transcutaneous Electrical Nerve Stimulators 55

3.3.2 Transcranial Magnetic Stimulation (TMS) 56

3.3.3 Pulsed Electromagnetic Field Therapy 57

3.3.4 Other Non-invasive Bioelectric Medicines 58

4 Segmentation of Europe Market by End User 59

4.1 Market Overview by End User 59

4.2 Hospitals and Clinics 61

4.3 Research Institutes 62

4.4 Individual Users 63

5 European Market 2020-2030 by Country 64

5.1 Overview of European Market 64

5.2 Germany 67

5.3 UK 69

5.4 France 71

5.5 Spain 73

5.6 Italy 75

5.7 Russia 77

5.8 Rest of European Market 79

6 Competitive Landscape 81

6.1 Overview of Key Vendors 81

6.2 New Product Launch, Partnership, Investment, and M&A 87

6.3 Company Profiles 88

Abbott Laboratories 88

BIOTRONIK SE & Co. KG 91

Boston Scientific Corporation 95

Cochlear Limited 99

electroCore, Inc. 102

Inspire Medical Systems, Inc. 104

LivaNova PLC 106

Medtronic PLC 108

NeuroMetrix, Inc 112

Nevro Corp. 114

Nuvectra Corporation 116

OMRON CORPORATION 118

Pixium Vision 121

Second Sight Medical Products Inc 124

SetPoint Medical 127

Sonova Holding AG 129

St. Jude Medical, Inc. 131

Stimwave LLC 133

7 Investing in Europe Market: Risk Assessment and Management 135

7.1 Risk Evaluation of Europe Market 135

7.2 Critical Success Factors (CSFs) 138

Related Reports and Products 141


List of Figure

Figure 1. Research Method Flow Chart 11

Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14

Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2030 16

Figure 4. Europe Bioelectric Medicine Market, 2019-2030, USD mn 18

Figure 5. Impact of COVID-19 on Business 21

Figure 6. Primary Drivers and Impact Factors of Europe Bioelectric Medicine Market 23

Figure 7. Worldwide Geriatric Population (60 years and above) by Region, 2015 & 2030, million 27

Figure 8. World Population 65 and over, % of Total Population, 1950-2060 27

Figure 9. Primary Restraints and Impact Factors of Europe Bioelectric Medicine Market 29

Figure 10. Investment Opportunity Analysis 33

Figure 11. Porter's Fiver Forces Analysis of Europe Bioelectric Medicine Market 36

Figure 12. Breakdown of Europe Bioelectric Medicine Market by Product Type, 2020-2030, % of Sales Revenue 40

Figure 13. Europe Addressable Market Cap in 2021-2030 by Product Type, Value (USD mn) and Share (%) 41

Figure 14. Europe Bioelectric Medicine Market: Implantable Bioelectric Medicine, 2019-2030, USD mn 42

Figure 15. Europe Bioelectric Medicine Market: Cardiac Pacemaker, 2019-2030, USD mn 44

Figure 16. Europe Bioelectric Medicine Market: Implantable Cardioverter Defibrillators (ICD), 2019-2030, USD mn 45

Figure 17. Europe Bioelectric Medicine Market: Spinal Cord Stimulators, 2019-2030, USD mn 46

Figure 18. Europe Bioelectric Medicine Market: Cochlear Implants, 2019-2030, USD mn 47

Figure 19. Europe Bioelectric Medicine Market: Deep Brain Stimulators, 2019-2030, USD mn 48

Figure 20. Europe Bioelectric Medicine Market: Vagus Nerve Stimulators, 2019-2030, USD mn 49

Figure 21. Europe Bioelectric Medicine Market: Sacral Nerve Stimulators, 2019-2030, USD mn 50

Figure 22. Europe Bioelectric Medicine Market: Retinal Implants, 2019-2030, USD mn 51

Figure 23. Europe Bioelectric Medicine Market: Other Implantable Bioelectric Medicines, 2019-2030, USD mn 52

Figure 24. Europe Bioelectric Medicine Market: Non-invasive Bioelectric Medicine, 2019-2030, USD mn 53

Figure 25. Europe Bioelectric Medicine Market: Transcutaneous Electrical Nerve Stimulators, 2019-2030, USD mn 55

Figure 26. Europe Bioelectric Medicine Market: Transcranial Magnetic Stimulation (TMS), 2019-2030, USD mn 56

Figure 27. Europe Bioelectric Medicine Market: Pulsed Electromagnetic Field Therapy, 2019-2030, USD mn 57

Figure 28. Europe Bioelectric Medicine Market: Other Non-invasive Bioelectric Medicines, 2019-2030, USD mn 58

Figure 29. Breakdown of Europe Bioelectric Medicine Market by End User, 2020-2030, % of Sales Revenue 59

Figure 30. Europe Addressable Market Cap in 2021-2030 by End User, Value (USD mn) and Share (%) 60

Figure 31. Europe Bioelectric Medicine Market: Hospitals and Clinics, 2019-2030, USD mn 61

Figure 32. Europe Bioelectric Medicine Market: Research Institutes, 2019-2030, USD mn 62

Figure 33. Europe Bioelectric Medicine Market: Individual Users, 2019-2030, USD mn 63

Figure 34. Breakdown of European Bioelectric Medicine Market by Country, 2019 and 2030, % of Revenue 65

Figure 35. Contribution to Europe 2021-2030 Cumulative Revenue by Country, Value (USD mn) and Share (%) 66

Figure 36. Bioelectric Medicine Market in Germany, 2019-2030, USD mn 67

Figure 37. Bioelectric Medicine Market in UK, 2019-2030, USD mn 69

Figure 38. Bioelectric Medicine Market in France, 2019-2030, USD mn 71

Figure 39. Bioelectric Medicine Market in Spain, 2019-2030, USD mn 73

Figure 40. Bioelectric Medicine Market in Italy, 2019-2030, USD mn 75

Figure 41. Bioelectric Medicine Market in Russia, 2019-2030, USD mn 77

Figure 42. Bioelectric Medicine Market in Rest of Europe, 2019-2030, USD mn 79

Figure 43. Growth Stage of Europe Bioelectric Medicine Industry over the Forecast Period 81


List of Table

Table 1. Snapshot of Europe Bioelectric Medicine Market in Balanced Perspective, 2020-2030 17

Table 2. Growth Rate of World GDP, 2020-2022 20

Table 3. Projection of Europe Disease Incidences Treated by Bioelectric Medicine, 2019-2030, million 26

Table 4. World Health Spending by Region, USD bn, 2013-2020 28

Table 5. Selected Examples of Product Recalls 31

Table 6. Main Product Trends and Market Opportunities in Europe Bioelectric Medicine Market 32

Table 7. Europe Bioelectric Medicine Market by Product Type, 2019-2030, USD mn 40

Table 8. Europe Implantable Bioelectric Medicine Market by Product Type, 2019-2030, USD mn 43

Table 9. Europe Bioelectric Medicine Market: Spinal Cord Stimulators by Application, 2019-2030, USD mn 46

Table 10. Europe Bioelectric Medicine Market: Deep Brain Stimulators by Application, 2019-2030, USD mn 48

Table 11. Europe Bioelectric Medicine Market: Sacral Nerve Stimulators by Application, 2019-2030, USD mn 50

Table 12. Europe Non-invasive Bioelectric Medicine Market by Product Type, 2019-2030, USD mn 54

Table 13. Europe Bioelectric Medicine Market by End User, 2019-2030, USD mn 59

Table 14. Europe Bioelectric Medicine Market by Country, 2019-2030, USD mn 66

Table 15. Germany Bioelectric Medicine Market by Product Type, 2019-2030, USD mn 68

Table 16. Germany Bioelectric Medicine Market by End User, 2019-2030, USD mn 68

Table 17. UK Bioelectric Medicine Market by Product Type, 2019-2030, USD mn 70

Table 18. UK Bioelectric Medicine Market by End User, 2019-2030, USD mn 70

Table 19. France Bioelectric Medicine Market by Product Type, 2019-2030, USD mn 72

Table 20. France Bioelectric Medicine Market by End User, 2019-2030, USD mn 72

Table 21. Spain Bioelectric Medicine Market by Product Type, 2019-2030, USD mn 74

Table 22. Spain Bioelectric Medicine Market by End User, 2019-2030, USD mn 74

Table 23. Italy Bioelectric Medicine Market by Product Type, 2019-2030, USD mn 76

Table 24. Italy Bioelectric Medicine Market by End User, 2019-2030, USD mn 76

Table 25. Russia Bioelectric Medicine Market by Product Type, 2019-2030, USD mn 78

Table 26. Russia Bioelectric Medicine Market by End User, 2019-2030, USD mn 78

Table 27. Bioelectric Medicine Market in Rest of Europe by Country, 2019-2030, USD mn 80

Table 28. Spinal Cord Stimulation Device Market by Key Vendor, 2019, % 83

Table 29. Cochlear Implant Market by Key Vendor, 2019, % 83

Table 30. Pacemaker and ICD Market by Key Vendor, 2019, % 83

Table 31. FDA Approved Products of Key Vendors 84

Table 32. Abbott Laboratories: Company Snapshot 88

Table 33. Abbott Laboratories: Business Segmentation 89

Table 34. Abbott Laboratories: Product Portfolio 89

Table 35. Abbott Laboratories: Revenue, 2018-2020, USD mn 90

Table 36. BIOTRONIK SE & Co. KG: Company Snapshot 91

Table 37. Boston Scientific Corp.: Company Snapshot 95

Table 38. Boston Scientific Corp.: Business Segmentation 95

Table 39. Boston Scientific Corp.: Product Portfolio of Medical Devices 96

Table 40. Cochlear Limited: Company Snapshot 99

Table 41. Cochlear Limited: Operational Overview with Sales Revenue (USD mn) and Sales Volume (units), 2020-2021 99

Table 42. Cochlear Limited: Product Portfolio 100

Table 43. electroCore, Inc.: Company Snapshot 102

Table 44. Inspire Medical Systems, Inc..: Company Snapshot 104

Table 45. LivaNova PLC: Company Snapshot 106

Table 46. LivaNova PLC: Product Portfolio 107

Table 47. Medtronic Inc.: Company Snapshot 108

Table 48. Medtronic Inc.: Net Revenue by Segment, 2018-2020, USD bn 109

Table 49. Medtronic Inc.: Net Revenue by Region, 2017-2019, USD bn 109

Table 50. Medtronic Inc.: Product Portfolio of Medical Devices 109

Table 51. Medtronic Inc.: Product Portfolio of Bioelectric Medicine 110

Table 52. NeuroMetrix, Inc: Company Snapshot 112

Table 53. NeuroMetrix, Inc: Product Portfolio 113

Table 54. Nevro Corp.: Company Snapshot 114

Table 55. Nevro Corp.: Product Portfolio 115

Table 56. Nuvectra Corporation: Company Snapshot 116

Table 57. Omron Corporation: Company Snapshot 118

Table 58. Omron Corporation: Business Segmentation 119

Table 59. Pixium Vision: Company Snapshot 121

Table 60. Pixium Vision: Product Portfolio 122

Table 61. Second Sight Medical Products Inc: Company Snapshot 124

Table 62. Second Sight Medical Products Inc: Product Portfolio 125

Table 63. SetPoint Medical: Company Snapshot 127

Table 64. Sonova Holding AG: Company Snapshot 129

Table 65. Sonova Holding AG: Main Brands and Products 130

Table 66. St. Jude Medical, Inc.: Company Snapshot 131

Table 67. Stimwave LLC: Company Snapshot 133

Table 68. Stimwave LLC: Product Portfolio 134

Table 69. Risk Evaluation for Investing in Europe Market, 2020-2030 136

Table 70. Critical Success Factors and Key Takeaways 139

You can also purchase parts of this report. Do you want to check out a section wise price list?

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022

What Our Clients Say About Us